April #143 : One... Two... C - by Laura Whitehorn

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Archives » POZ Magazine issues

Table of Contents

Just Add Water

Sweet Home Alabama

Halftime Show

Late Date

One... Two... C

Playing the Circuit

Who's Your Caddy?

New Med in Town

The Wire

Micro Managing

Tax and Tip

No Fly Zone

Male Call

Dummy Up, Mom

Show Girl


French Fried

Disco Disclosure

Eco Chamber

It's Raining Rihanna

Trump's HIV Apprentice

Caribbean Queen

On-the-Job Training

Choke Hold

Mailbox-April 2008

Editor's Letter--April 2008

The NAPWA/TAEP HIV/AIDS Policy Report-April 2008

GMHC Treatment Issues-April 2008

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

Scroll down to comment on this story.

email print

April 2008

One... Two... C

by Laura Whitehorn

Predicting whether hepatitis C treatment will work for you—and what to do if it doesn’t

More than one quarter of HIV-positive Americans also have hepatitis C (HCV). A new study shows that if you are coinfected, and if HCV therapy gets your hepatitis viral load to undetectable after four weeks, you may well succeed in clearing HCV. But what if you’re not among the undetectables?

Standard hep C therapy for coinfected people is pegylated interferon (Pegasys, Peg-Intron) and ribavirin (Rebetol, Copegus) for 48 weeks. This routine often fails, especially in those with the common, hard-to-treat HCV genotype 1 strain. The therapy also has some miserable side effects including fatigue, muscle aches, anemia and depression.

If HCV isn’t undetectable at four weeks, says Mark Sulkowski, MD, of Baltimore’s Johns Hopkins Medical School, tests at eight and then 12 weeks may show improvement. “If there continues to be no significant reduction and viral load is about 500,000,” he says, “I’ll stop treatment.”

Some researchers think the therapy benefits liver health even when it doesn’t clear HCV. But Raymond Chung, MD, of Harvard Medical School, says this may not work for HIV/HCV coinfection—and a study released at the February ’08 Conference on Retroviruses and Opportunistic Infections backs him up. For people battered by those infamous side effects (like “the flu from hell,” say some who’ve been there), quitting the drugs may offset the disappointment of failure.

Both Sulkowski and Chung agree that if you’re not among the success stories, there are steps you can take to boost the health of your liver: Avoid alcohol, keep your weight and body-mass index within healthy limits, and control your HIV. They add that new HCV treatments, including protease inhibitors, are being studied, and that diabetes drugs are also under examination for hep C therapy.

Diabetes meds may help promote HCV treatment success by improving one source of liver damage, fatty liver. And if you’re recently diagnosed with HCV, note that starting treatment early seems to work best.     

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Hide comments

Previous Comments:


[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.